Free Webex Call
The Global Advanced Balloon Catheter Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the rising prevalence of different chronic heart diseases and growing geriatric populations across the region. The increasing demand for minimally invasive procedures in emerging countries and the development of advanced cardiovascular devices will further enhance the overall market demand for balloon catheters during the forecast period. The other factors supporting the market’s growth are the growing incidence of cancers in the pelvic region affecting the urinary system along with the technical development of drug-coated balloon catheters aimed at drug delivery at the site of action is expected to propel the growth of the market. Moreover, the rise in the research and development activities in the medical sector and the rise in the adoption of various new technology are the contributing factors to the growth of the market.Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Increasing prevalence of cardiovascular diseases across the globe
The increasing prevalence of coronary heart disease and deaths occurring in emerging countries due to a lack of health care services in rural areas is expected to create lucrative growth during the forecast period. According to the Central For Diseases Control, Every year, about 805,000 people in the United States have a heart attack and about 1 in 5 heart attacks are silent, the damage is done, but the person is not aware of it. Similarly, increasing need for surgical intervention for the treatment of cardiovascular disorders enhances the demand for Percutaneous Transluminal Angioplasty (PTA) balloon catheters during the forecast period. According to a research article published by the NCBI in 2018, more than 200 million people suffer from Peripheral Artery Disease (PAD) across the globe.Advancements in surgical procedure propel the market growth
Growing demand for angioplasty over conventional surgery has gained a significant preference among patients due to its minimally invasive procedure and better outcomes which are expected to create lucrative growth during the forecast period. Peripheral artery diseases majorly include this procedure for the use of catheters to clear blocked arteries. Similarly, the growing demand for minimally invasive surgeries along with increasing the number of catheterization laboratories across the region is expected to create lucrative growth during the forecast period. Also, growing initiatives and investments by government and private organizations for the development of healthcare infrastructure in underdeveloped regions will further propel the market growth during the forecast period. According to the American Cancer Society’s estimates for bladder cancer in the United States for 2022 are about 81,180 new cases of bladder cancer (about 61,700 in men and 19,480 in women) and about 17,100 deaths from bladder cancer (about 12,120 in men and 4,980 in women).Favourable Reimbursement Landscape in Developed Economies Foster the Market Growth
In the developing region, the reimbursement procedure depends on the citizen’s fulfilment of the prerequisites documents so some developing countries like the U.S, the UK, Canada, and Japan have this procedure which will enhance the growth of the healthcare sector during the forecast period. However, different private insurance company also provide the reimbursement procedure for patients other than angioplasties procedures like kyphoplasty and sinuplasty are also reimbursed which will boost the market growth over the years. However, in Europe, in the case of usage of advanced balloon catheters, like drug-coated balloon catheters for a procedure, additional reimbursement is also offered considering the high cost of the device. Thus, the favourable reimbursement landscape for angioplasties and other balloon catheter procedures will significantly impact the sales of advanced balloon catheters.Market Segmentation
The global advanced balloon catheter market is segmented into raw material type, application, end users, and region. Based on raw material type, the market can be segmented into Nylon, PET, Polyurethane, and Others. Based on the application, the market can be segmented into Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, and Other Procedures. Based on end users, the market can be differentiated into Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, and Others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the growing demand for advanced technology used for the treatment of cardiovascular diseases in the country.Recent Development
According to a press release, Advance Serenity is a hydrophilic-coated angioplasty balloon catheter designed to meet the technical needs of clinicians for treatment of patients who suffer from Peripheral Artery Disease (PAD) which includes below-the-knee disease.Market Players
Abbott Laboratories., Boston Scientific Corporation., Medtronic plc,Terumo Corporation, MicroPort, Scientific Corporation, B. Braun Melsungen AG, Meril Life Sciences Pvt. Ltd., Hexacath, Tokai Medical Products Inc. are some of the leading players operating in the global advanced balloon catheter market.Report Scope:
In this report, the global advanced balloon catheter market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Advanced Balloon Catheter Market, By Raw Material Type:
- Nylon
- PET
- Polyurethane
- Others
Advanced Balloon Catheter Market, By Application:
- Coronary Procedures
- Peripheral Procedures
- Neurovascular Procedures
- Other Procedures
Advanced Balloon Catheter Market, By End-Users:
- Hospitals and Ambulatory Surgical Centers
- Catheterization Laboratories
- Others
Advanced Balloon Catheter Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Advanced Balloon Catheter Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:Company Information
Detailed analysis and profiling of additional market players (up to five).This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Global Advanced Balloon Catheter Market Outlook
6. North America Advanced Balloon Catheter Market Outlook
7. Europe Advanced Balloon Catheter Market Outlook
8. Asia-Pacific Advanced Balloon Catheter Market Outlook
9. South America Advanced Balloon Catheter Market Outlook
10. Middle East and Africa Advanced Balloon Catheter Market Outlook
11. Market Dynamics
12. Market Trends & Developments
14. Porter’s Five Forces Analysis
15. Competitive Landscape
Companies Mentioned
- Abbott Laboratories.
- Boston Scientific Corporation.
- Medtronic plc
- Terumo Corporation
- MicroPort
- Scientific Corporation
- B. Braun Melsungen AG
- Meril Life Sciences Pvt. Ltd.
- Hexacath
- Tokai Medical Products Inc.